Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

February 01, 1996; Volume 24,Issue 2
  • You have access
    Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues.
    C C Ho, T H Lin, Y S Lai, J G Chung, G N Levy and W W Weber
    Drug Metabolism and Disposition February 1996, 24 (2) 137-141;
  • You have access
    Inhibition of the intestinal digoxin absorption and exsorption by quinidine.
    S F Su and J D Huang
    Drug Metabolism and Disposition February 1996, 24 (2) 142-147;
  • You have access
    Tissue distribution and pharmacokinetics of centchroman. A new nonsteroidal postcoital contraceptive agent and its 7-desmethyl metabolite in female rats after a single oral dose.
    J K Paliwal and R C Gupta
    Drug Metabolism and Disposition February 1996, 24 (2) 148-155;
  • You have access
    Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    G P Schoenig, R E Hartnagel, T G Osimitz and S Llanso
    Drug Metabolism and Disposition February 1996, 24 (2) 156-163;
  • You have access
    Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes.
    Y Irshaid, R A Branch and A Adedoyin
    Drug Metabolism and Disposition February 1996, 24 (2) 164-171;
  • You have access
    Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats.
    Y N Wong, C Y Quon, K A Holm, D L Burcham, N L Frey, S M Huang and G N Lam
    Drug Metabolism and Disposition February 1996, 24 (2) 172-179;
  • You have access
    Hydroxylation of lauramide diethanolamine by liver microsomes.
    J Merdink, K Decosta, J M Mathews, C B Jones, J R Okita and R T Okita
    Drug Metabolism and Disposition February 1996, 24 (2) 180-186;
  • You have access
    In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.
    Z Zhao, K A Koeplinger, G L Bundy, L S Banitt, G E Padbury, M J Hauer and P E Sanders
    Drug Metabolism and Disposition February 1996, 24 (2) 187-198;
  • You have access
    Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
    K Sugihara, S Kitamura and K Tatsumi
    Drug Metabolism and Disposition February 1996, 24 (2) 199-202;
  • You have access
    Modeling the cytochrome P450-mediated metabolism of chlorinated volatile organic compounds.
    C L Waller, M V Evans and J D McKinney
    Drug Metabolism and Disposition February 1996, 24 (2) 203-210;
  • You have access
    Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
    C M Ervine, D E Matthew, B Brennan and J B Houston
    Drug Metabolism and Disposition February 1996, 24 (2) 211-215;
  • You have access
    Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat. Accelerative effect of bile on intestinal absorption of diclofenac.
    K Tabata, K Yamaoka, T Fukuyama and T Nakagawa
    Drug Metabolism and Disposition February 1996, 24 (2) 216-220;
  • You have access
    Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture.
    E L Sun, K L Feenstra, F P Bell, P E Sanders, J G Slatter and R G Ulrich
    Drug Metabolism and Disposition February 1996, 24 (2) 221-231;
  • You have access
    Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention.
    E A Eaton, U K Walle, A J Lewis, T Hudson, A A Wilson and T Walle
    Drug Metabolism and Disposition February 1996, 24 (2) 232-237;
  • You have access
    3,3',4,4'-tetrachloroazobenzene absorption, disposition, and metabolism in male Fischer 344 rats.
    U A Pillai, T L Ziegler, D X Wang, M J Kattnig, T McClure, D C Liebler, M Mayersohn and I G Sipes
    Drug Metabolism and Disposition February 1996, 24 (2) 238-244;
  • You have access
    Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
    C R Wagner, C P Bergstrom, K R Koning and P E Hanna
    Drug Metabolism and Disposition February 1996, 24 (2) 245-253;
  • You have access
    Effect of 3-methylcholanthrene on bunitrolol metabolism. Kinetics and immunological studies on 4-hydroxylation of bunitrolol catalyzed by two species of cytochromes P450 in rat liver microsomes.
    S Fujita, M Masuda, Y Shimamoto, H Hoshi, S Kariya, A Kazusaka and T Suzuki
    Drug Metabolism and Disposition February 1996, 24 (2) 254-259;
  • You have access
    Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase).
    B C Jones, G Hawksworth, V A Horne, A Newlands, J Morsman, M S Tute and D A Smith
    Drug Metabolism and Disposition February 1996, 24 (2) 260-266;
  • You have access
    Pharmacokinetics and biodistribution of 131I-labeled trigalactose conjugate of streptavidin.
    M Hashmi and S F Rosebrough
    Drug Metabolism and Disposition February 1996, 24 (2) 267-269;
  • You have access
    Influence of probenecid on the renal excretion mechanisms of cefadroxil.
    M J Gimeno, M Martínez, L Granero, F Torres-Molina and J E Peris
    Drug Metabolism and Disposition February 1996, 24 (2) 270-272;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 24, Issue 2
1 Feb 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics